Social Media Ideas for Mrk

Merck: 'Strong Buy' Lipfendra FDA First And Continued Oncology Expansions

Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engin...

Merck KGaA (MKKGY) Q2 2026 Earnings Call Transcript

Analyst Report: Merck & Co Inc

<![CDATA[M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration wit...

Merck, Moderna report positive Phase 3 melanoma results for Keytruda combination

Rahway-based Merck and Moderna said Aug. 19 that a Phase 3 trial of an investigational mRNA-based cancer therapy used in combination with Keytruda met its primary and key secondary...

Merck is a buy as strong cancer drug pipeline offsets Keytruda patent expiration, Morgan Stanley says

Merck, which makes the popular cancer treatment Keytruda, is poised to gain ground as its pipeline drugs get close to coming to market, per Morgan Stanley.

<![CDATA[M&A Roundup: Pathos AI Enter’s Licensing Agreements with AstraZeneca & Alphamab Oncology, Curium Ent...

Morguard Real Estate Investment Trust (MRT.UN:CA) Q2 2026 Earnings Call Transcript

Why Moderna's Cancer Vaccine Matters To Investors

Milestone

Milestone Anonymous (not verified) Tue, 07/28/2026 - 18:24 field_thread_url https://cafepharma.com/boards/threads/milestone.694258/ boar...

<![CDATA[M&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquire...

Markel Group Inc. announces conference call date and time 

  RICHMOND, Va., July 24, 2026 /PRNewswire-HISPANIC PR WIRE/ — Markel Group Inc. (NYSE: MKL) announced today it will ...

<![CDATA[Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million ]]>

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Merck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combination

After keeping tight-lipped for nearly two years, Merck & Co. briefly dropped the first concrete hint as to where it intends to take its PD-1xVEGF bispecific antibody—before qui...

Milestone

Milestone Anonymous (not verified) Fri, 08/21/2026 - 06:38 field_thread_url https://cafepharma.com/boards/threads/milestone.694258/ boar...

SA Asks: What are the most promising oncology companies right now?

What This MannKind Sale Signals With Tyvaso Royalties at $32.7 Million

This disposition was tied to vesting of performance-based RSUs at 83% of the target.

<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>

Recent Results From Marex Group Impress, But Some Risks Are Rising

5 Undervalued Winners Up To 6.8% And 15 Overvalued To Avoid Now

SA Asks: What's the outlook for Big Pharma M&A?

<![CDATA[M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Part...